Massmutual Trust CO Fsb Nektar Therapeutics Transaction History

Massmutual Trust CO Fsb

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 06, 2023	BUY	$2.03 - $4.28 $434 - $915	214 Added 36.96%	793 $2,000
Q3 2022 Oct 07, 2022	BUY	$3.04 - $5.14 $1,760 - $2,976	579 New	579 $2,000
Q1 2022 Apr 08, 2022	SELL	$4.16 - $13.72 $640 - $2,112	-154 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$10.83 - $18.41 $1,667 - $2,835	154 New	154 $2,000
Q3 2018 Nov 09, 2018	SELL	$46.46 - $68.49 $0 - $0	0 Closed	0 $0
Q2 2018 Aug 20, 2018	BUY	$46.25 - $104.45 $0 - $0	0 New	0 $0

145

139M

32.6K

14.1K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $174M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Massmutual Trust CO Fsb, based on Form 13F filings with the SEC.

Stay updated on Massmutual Trust CO Fsb with notifications on news.